Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04471779 · ClinicalTrials.gov registry record · NA
Information About Alzheimer's Disease for Latinos in New York City
A NA study of Alzheimer Disease, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 374
- Enrollment target
- 1
- Study location
NCT04471779 is a NA study of Alzheimer Disease that has completed, run by Columbia University. The registered enrollment target is 374 participants, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04471779, a NA study of Alzheimer Disease, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 374 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the psychosocial and behavioral impacts of receiving Alzheimer's disease genetic risk assessment incorporating APOE genotypes among Latinos in northern Manhattan. The investigators will conduct a longitudinal, community-based study with a mixed methods design. Participants will be randomized to learn about their lifetime risk of late-onset Alzheimer's disease (AD) based either on (a) Latino ethnicity and family history alone (genotype nondisclosure group), or (b) the same factors plus APOE genotype (genotype disclosure group). Responses will be evaluated at 6 weeks, 9 months, and 15 months after risk assessment. In the quantitative component of the study, the investigators will assess psychosocial outcomes, memory test performance, and health-related behaviors. In the qualitative component of the study, the investigators will investigate the lived experience of receiving personal AD risk information, using a stress and coping theoretical framework.
Conditions Studied
Interventions
- OTHER Disclosure of APOE genotype
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 374 participants |
| Start Date | 2021-08-13 |
| Est. Completion | 2025-10-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04471779
The ClinicalTrials.gov registry entry for NCT04471779 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 374 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (86% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Disclosure of APOE genotype is the first listed.
NCT04471779 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04471779 about?
NCT04471779 is a clinical study titled "Information About Alzheimer's Disease for Latinos in New York City". This study will assess the psychosocial and behavioral impacts of receiving Alzheimer's disease genetic risk assessment incorporating APOE genotypes among Latinos in northern Manhattan. The investigators will conduct a longitudinal, community-based study with a mixed methods design. Participants wil...
What is the current status of trial NCT04471779?
This trial is currently completed. It is a NA study. The enrollment target is 374 participants. The study started on 2021-08-13. Estimated completion is 2025-10-03.
What conditions does trial NCT04471779 study?
This clinical trial studies the following conditions: Alzheimer Disease.
What interventions are being tested in trial NCT04471779?
The interventions under investigation include: Disclosure of APOE genotype (OTHER).
Who is sponsoring clinical trial NCT04471779?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04471779 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.